Breast cancer chemoprevention research hub

An international multicentre study of tamoxifen versus placebo in women at increased risk of breast cancer

This study looks at whether a daily medicine called tamoxifen can lower the risk of breast cancer in women who have a higher chance of developing it. Researchers compare tamoxifen with a dummy pill (placebo) to find out how safe and effective it is at preventing the disease.